DiaMedica Therapeutics Inc’s filing revealed that its 10% Owner STAHLBERG JAN acquired Company’s shares for reported $5.4 million on Jul 23 ’25. In the deal valued at $3.50 per share,1,542,857 shares were bought. As a result of this transaction, STAHLBERG JAN now holds 6,764,465 shares worth roughly $35.31 million.
Then, Von Koch Thomas bought 2,857,142 shares, generating $9,999,997 in total proceeds. Upon buying the shares at $3.50, the 10% Owner now owns 8,383,577 shares.
Before that, JACINTO RICHARD II bought 400,000 shares. DiaMedica Therapeutics Inc shares valued at $1,400,000 were divested by the 10% Owner at a price of $3.50 per share. As a result of the transaction, JACINTO RICHARD II now holds 4,958,823 shares, worth roughly $25.89 million.
H.C. Wainwright initiated its DiaMedica Therapeutics Inc [DMAC] rating to a Buy in a research note published on October 07, 2024; the price target was $7. Oppenheimer also remained covering DMAC and has increased its forecast on June 22, 2023 with a “an Outperform” recommendation from previously “Perform” rating. Oppenheimer started covering the stock on April 09, 2021. It rated DMAC as “an Outperform”.
Price Performance Review of DMAC
On Tuesday, DiaMedica Therapeutics Inc [NASDAQ:DMAC] saw its stock jump 13.97% to $5.22. Over the last five days, the stock has gained 16.26%. DiaMedica Therapeutics Inc shares have risen nearly 55.82% since the year began. Nevertheless, the stocks have fallen -3.87% over the past one year. While a 52-week high of $6.82 was reached on 02/19/25, a 52-week low of $3.19 was recorded on 04/07/25.
Levels Of Support And Resistance For DMAC Stock
The 24-hour chart illustrates a support level at 4.82, which if violated will result in even more drops to 4.41. On the upside, there is a resistance level at 5.44. A further resistance level may holdings at 5.65.
How much short interest is there in DiaMedica Therapeutics Inc?
A steep rise in short interest was recorded in DiaMedica Therapeutics Inc stocks on 2025-07-31, growing by 1.16 million shares to a total of 3.28 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 2.12 million shares. There was a rise of 35.36%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 17, 2021 when ROTH Capital began covering the stock and recommended ‘”a Buy”‘ rating along with a $38 price target.
